Advancing from NK Cells to Commercial NK Cell Therapies
The 4th Innate Killer Summit is an annual industry meeting providing a platform for leaders in the NK field to network, interact and learn at the only end-to-end meeting that fosters the transformation of leading science to commercial therapies.
As the understanding of NK cells improves year on year, the challenges of producing effective NK cell therapies are top priorities to overcome. Manufacturing processes need to be streamlined and regulatory landscapes better understood. It is imperative that we can come together to exchange ideas to overcome the hurdles of getting the best immunotherapies to patients in need.
In addition to accessing cutting-edge novel innovations and the latest clinical data, leave the Innate Killer Summit fully equipped to progress your NK cell therapy pipeline with a forward-looking plan for global manufacturing.
Join the leading scientific and business experts from all the key stakeholders to identify future approaches to deliver commercially viable off-the-shelf therapies.
“Fantastic overview of the state of the art of the NK cell therapy field in particular, with great representation of the key players”
Neil Sheppard, Director, Head External Cooperations Oncology Cell Therapy, GSK
“The meeting was excellent. Fantastic presentations on the basic science as well as clinical experience.”
“Intimate setting where scientists and clinicians can have focused discussions around NK cell biology and clinical translation.”